EastGate Biotech Discusses Their Phase 3 Clinical Trials and Recent Coronavirus Agreement

from Stock Day Media · host Stock Day Media

The Stock Day Podcast welcomed EastGate Biotech (ETBI)(“the Company”), a company that focuses on innovative technological developments and produces and distributes innovative drug compounds and healthy nutraceuticals that are based on natural therapies absorbed by the body. CEO of the Company, Anna Gluskin, and President of the Company, Rose Perri, joined Stock Day host Everett Jolly. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Episode metadata supplied by the publisher feed · Published Feb 5, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

EastGate Biotech Discusses Their Phase 3 Clinical Trials and Recent Coronavirus Agreement

0:00 5:53

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of Stock Day Media?

This episode is 5 minutes long.

When was this Stock Day Media episode published?

This episode was published on February 5, 2020.

Can I download this Stock Day Media episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!